RELIQ HEALTH TECHS INC - RQHTF STOCK NEWS

Reliq Health Technologies Inc. (RQHTF), a fast-growing telemedicine company, will participate in the Lytham Partners Summer 2021 Investor Conference from June 14-16, 2021. CEO Dr. Lisa Crossley is set to present and engage in a fireside chat on June 15 at 3:30 PM ET. A webcast of the event will be available on their website and archived for replay. Dr. Crossley will also hold one-on-one meetings during the conference. Reliq specializes in innovative Virtual Care solutions and aims to improve healthcare delivery using its iUGO Care platform.

Reliq Health Technologies (OTCQB:RQHTF) announced the availability of its Q3 FY2021 interim financial statements and provided a corporate update. The company expects revenue to exceed $1.5 million per quarter by the end of FY2021, driven by the U.S. COVID-19 vaccination rollout. Notable achievements include a significant increase in working capital and multiple contracts signed for their iUGO Care platform. Revenue projections for calendar year 2021 are set at $11 million, with gross margins exceeding 75%. A webinar is scheduled to review financials, with annual results due by October 28, 2021.

Reliq Health Technologies Inc. (OTC:RQHTF) has resumed onboarding with Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) following a decline in COVID-19 cases in the US. The company aims to onboard over 27,000 patients in the next year, utilizing its Remote Patient Monitoring and other services. Expected revenue is approximately $50 per patient monthly. Reliq's iUGO Care platform supports better healthcare access and patient outcomes, vital for the company's growth in the telemedicine sector.

Reliq Health Technologies Inc. (OTC:RQHTF) announced a webinar on June 1, 2021, to discuss Q3 FY2021 financial results and company updates. CEO Dr. Lisa Crossley stated the company aims for profitability by June 2021, essential for its planned NASDAQ uplisting. Reliq forecasts $11 million in revenue for the year, with gross margins of 75% and EBITDA margins of 45%. The company is expanding its Care Management team to meet increasing demand, bolstered by successful vaccine rollouts and state reopenings.

Reliq Health Technologies (OTC:RQHTF) announced the acquisition of four new Skilled Nursing Facility clients in the Southern US, signaling increased demand for its Care Management Services. The company’s iUGO Care platform offers various services to improve patient health outcomes and generate new revenue streams for clients, averaging $50 per patient per month. Reliq is also expanding its Care Management team to meet this demand, with potential revenues of $100 per patient per month for its premium service. The company aims to enhance care coordination through its telemedicine solutions.

Reliq Health Technologies Inc. (OTC:RQHTF) has adopted the FHIR standard for its iUGO Care platform, enhancing interoperability for large-scale enterprise clients, including managed care plans. This move aligns with new CMS regulations aimed at improving healthcare data exchange. The company has also appointed Dave McKay as the new Chief Technology & Innovation Officer, bringing over 30 years of experience in healthcare technology. The previously held positions of Chief Technology Officer and Chief Innovation Officer have been eliminated, streamlining leadership as Reliq targets market expansion in 2021.

Reliq Health Technologies Inc. (OTC:RQHTF) announced new contracts with two US Nephrology practices for its iUGO Care platform, aimed at managing Chronic Kidney Disease (CKD) patients. The platform facilitates home monitoring, enhancing patient care and reducing costs. Dr. Lisa Crossley, CEO, highlighted the growing demand for iUGO Care, especially post-COVID-19 vaccine rollout. Reliq expects to earn an average of $65 USD per patient per month under these contracts. This marks a significant expansion into the Nephrology sector, supporting better health outcomes for CKD patients.

Reliq Health Technologies Inc. (OTC:RQHTF) announced two contracts with Texas-based orthopedic practices, leveraging the iUGO Care platform. This initiative aims to manage chronic orthopedic and post-operative patients remotely, providing an average revenue of $50 USD per patient per month. The CEO noted the acceleration of business post-vaccine rollout, with expectations of achieving profitability by the current quarter. The iUGO Care platform enhances patient care, particularly for chronic conditions, while reducing healthcare costs and improving health outcomes.

Reliq Health Technologies (OTC:RQHTF) has signed a contract with its first Orthopedic Practice in Texas, expanding its iUGO Care platform to manage chronic orthopedic and post-operative patients at home. The platform taps into a significant market, with over 5.7 million arthritis patients in Texas. Reliq anticipates onboarding patients in April, generating an average of $50 per patient monthly, leading to potential annual billings of over $500,000 for practices. This development aligns with the rising demand for virtual healthcare solutions post-vaccine rollout.